Phase I dose escalation study of pan-histone deacetylase (HDAC) inhibitor abexinostat in combination with cisplatin in patients with advanced non-keratinizing nasopharyngeal carcinoma.
Boon C. Goh
No relevant relationships to disclose
Ruey-Long Hong
No relevant relationships to disclose
Wan-Teck Lim
No relevant relationships to disclose
Frédérique Cantero
Employment or Leadership Position - Institut de Recherches Internationales Servier (I. R. I. S.)
Chee-Seng Tan
No relevant relationships to disclose
Renata Robert
Employment or Leadership Position - Institut de Recherches Internationales Servier (I. R. I. S.)